Free Trial

Jushi (OTCMKTS:JUSHF) Trading Down 2.3% - Should You Sell?

Jushi logo with Medical background

Key Points

  • Jushi Holdings Inc. shares fell by 2.3% during trading, reaching a low of $0.56 and last trading at $0.64.
  • The company reported a revenue of $65.05 million for the quarter, slightly exceeding the consensus estimate of $64.67 million.
  • Jushi has a market capitalization of $124.88 million and a negative P/E ratio of -2.19, indicating potential financial struggles.
  • Want stock alerts on Jushi? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report)'s stock price fell 2.3% during trading on Wednesday . The company traded as low as $0.56 and last traded at $0.64. 560,999 shares traded hands during mid-day trading, an increase of 48% from the average session volume of 379,166 shares. The stock had previously closed at $0.65.

Jushi Stock Up 7.1%

The firm has a market capitalization of $133.10 million, a price-to-earnings ratio of -2.33 and a beta of -0.98. The stock has a 50 day moving average of $0.40 and a 200 day moving average of $0.35.

Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.06) EPS for the quarter, hitting analysts' consensus estimates of ($0.06). The firm had revenue of $65.05 million during the quarter, compared to analyst estimates of $64.67 million. Analysts predict that Jushi Holdings Inc. will post -0.23 earnings per share for the current year.

Jushi Company Profile

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

See Also

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines